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Significance of this study
What is already known about this subject?
 ► Despite growing evidence on the importance of 
self-monitoring of blood glucose (SMBG) as a key 
component of diabetes self-management, there is 
wide variation in individual SMBG practice, with the 
clinical benefits identified from experimental studies 
often not replicated in observational studies.
What are the new findings?
 ► This multicase study has established that people 
with insulin-treated diabetes are able to provide 
immediate motives for why they self-monitor their 
blood glucose at particular times, with the same 
person often having different motives on different 
occasions.
 ► The motives are strongly influenced by underlying 
attitudes toward diabetes, with motive and attitudes 
influencing the action taken in response to the test 
result.
How might these results change the focus of 
research or clinical practice?
 ► It is important to have individualized understanding 
of SMBG in a real-world context in order to advise 
people with diabetes as to how SMBG can be opti-
mized for them.
AbStrAct
Objective To explore how and why self-monitoring 
of blood glucose (SMBG) is carried out in a real-world 
context. 
Research design and methods We conducted a 
multicase study among ten people with type 1 and insulin-
treated type 2 diabetes mellitus in Scotland, alongside 
seven nominated support people and four healthcare 
professionals. All participants were interviewed in depth 
and six participants provided SMBG diaries. Stones’ 
version of structuration theory informed the analysis.
Results People with diabetes were able to provide 
immediate motives for SMBG at particular times, often 
having different motives on different occasions. We 
identified six such motives, including routine, in response 
to symptoms, associated with a diabetes review, to 
facilitate lifestyle, when a ‘good’ result was expected, 
and higher level motives for longer term glycemic control. 
These motives were influenced by underlying attitudes 
toward diabetes that included level of engagement and 
responsibility for diabetes, a desire not to be controlled by 
diabetes, resistance to diabetes, diabetes education and 
relationship with the health service, fear of hypoglycemia, 
and prevention of diabetes complications. Five responses 
to test results were identified, depending on the immediate 
motive and underlying attitudes.
Conclusions People with insulin-treated diabetes do not 
necessarily self-monitor with an explicit goal of improving 
long-term glycemic control, but may have other motives 
that are important to them. An individualized understanding 
is therefore needed to advise people with diabetes how 
SMBG can be optimized for them.
InTROduCTIOn
Clinical guidelines recommend regular indi-
vidualized self-monitoring of blood glucose 
(SMBG) as a tool for self-management in type 
1 diabetes mellitus (four times daily)1 and in 
people with type 2 diabetes who are treated 
with insulin.2 Despite growing evidence on 
the importance of SMBG as a key component 
of self-management, many people who are 
recommended to test routinely are not testing 
as frequently as recommended, and many are 
not testing at all.3 There is also wide variation 
in individual practice of SMBG: frequency, 
timing, the measurement itself, interpreta-
tion of readings, resulting actions taken, and 
evaluation of the outcome.4 These wide vari-
ations in practice may account for why clin-
ical benefits identified from experimental 
studies that require SMBG to be undertaken 
according to strict protocols are often not 
replicated in observational studies.5 For this 
reason, it is important that individual self-man-
agement in diabetes is studied in a real-world 
context.6 We have conducted a multicase study 
among insulin-treated people with type 1 and 
type 2 diabetes mellitus in Scotland to explore 
in depth how and why they carry out SMBG 
within the context of their daily lives.
ReseaRCH desIgn and meTHOds
This study used a multicase study approach7 
to explore processes and behaviors around 
SMBG among people with diabetes in 
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Scotland. Each case comprised an individual with type 1 
or insulin-treated 2 diabetes mellitus (the patient partic-
ipant), along with a support person and/or a health-
care professional (HCP). The data were supplemented 
with blood glucose monitoring diaries for six patient 
participants.
People with diabetes were recruited from diabetic 
outpatient services within an NHS Health Board in Scot-
land, UK. Sixteen eligible people were identified and 
consented by their clinician to consent to speak with the 
researcher (DC) who provided a face-to-face overview of 
the study. The eligibility criteria specified that individuals 
be over the age of 18 years, have type 1 or insulin-treated 
type 2 diabetes mellitus, were English-speaking and had 
the capacity to consent. A convenience sampling tech-
nique was used iteratively to ensure that recruitment 
continued until the sample captured sufficient diversity 
in terms of age, sex, diabetes type and duration, and 
socioeconomic status. Potential participants were then 
asked to complete a ‘consent to contact’ form with their 
contact details and to identify a key support person: 
this could be a friend, relative, or work colleague; or an 
individual who supported them in some way with their 
diabetes. They also identified a key HCP who assisted 
with their diabetes management: this could be their 
diabetes consultant, diabetes specialist nurse, dietitian, 
practice nurse, general practitioner, or podiatrist. They 
were given ‘consent to contact’ forms to pass on to these 
individuals. The researcher proceeded to recruit and 
take informed consent from all individuals who provided 
contact details.
The final sample consisted of 10 cases (21 individuals). 
Ten patient participants agreed to take part, along with 
seven support people, and four HCPs identified by four 
patient participants. One patient participant was unable 
to identify a support person, and two support people did 
not return their consent to be contacted. Six HCPs did 
not return consent. This was a relatively large sample size 
for a case study, with detailed information from several 
sources available for each case.
Prior to fieldwork commencing among these partic-
ipants, two pilot telephone interviews were carried out 
with the support people of patients with diabetes (one 
mother, one daughter-in-law), and three people with 
diabetes were asked to complete patient diaries. Indepth, 
semistructured, face-to-face interviews were then under-
taken with each of the patient participants by DC. Seven 
of these interviews were undertaken in the participant’s 
home and three on university premises; all were audio-re-
corded, with only the participant and the interviewer 
present, and lasted around 1 hour. Participants were 
then provided with a diary to complete with the details 
of all SMBG that they undertook over any 2-week period. 
Telephone interviews were carried out with the HCPs and 
support people and lasted between 30 and 45 min. Inter-
views were audio-recorded and transcribed verbatim. 
Question guides were used during all interviews, but the 
semistructured nature allowed the interviewer to explore 
emerging areas of interest during the process. Finally, 
one HCP (a diabetes consultant) was asked to read and 
comment on all patient diaries.
All recruitment and fieldwork were carried out by DC, 
who had no previous contact with any of the partici-
pants. Field notes were made during the recruitment and 
interview processes. DC has a background in primary 
care practice and community nursing, which involved 
general diabetes management and the management of 
diabetes clinics. The participants were made aware of her 
background in the Participant Information Sheet, and 
this understanding facilitated effective communication 
between them, encouraging indepth conversation and 
exploration of the topic. However, DC took care to avoid 
making clinical assumptions based on previous experi-
ence, and she had no access to hemoglobin A1c (HbA1c) 
results or other clinical data of participants.
An interpretive approach to analysis was facilitated by 
use of QSR NVivo (V.11) software for first stage coding of 
the data. A constant comparative method was applied,8 
commencing with open coding, leading to the devel-
opment of conceptual categories. Stones’ structuration 
theory was used to guide the theory generation stage of 
analysis.9 Structuration theory posits that individual deci-
sion making and actions are dependent on a person’s 
nature and capabilities, which in turn are affected by 
wider structures. Informed by this theory, we mapped 
the analytical concepts on to underlying attitudes and 
beliefs and how these influenced immediate motives for 
testing, as well as how they affected subsequent actions 
and responses to test results. Thus we created a concep-
tual model for SMBG practice. Variations in views were 
considered and data re-examined to identify and explain 
disconfirming evidence. An epidemiologist (JMME) and 
a medical anthropologist (FH) helped to ensure that 
wider perspectives informed the analysis.
ResulTs
The characteristics of the ten cases (ten patient partic-
ipants with seven support people, four HCPs and 
six diaries) are presented in table 1. All names are 
pseudonyms.
Data from the pilot interviews and diaries were also used 
in the final analysis where it was felt that they contributed 
to interpretation. Initial analysis revealed varying expla-
nations for why and how people with diabetes self-mon-
itor their blood glucose. Participants were able to provide 
immediate reasons (which we have defined as immediate 
motives) for why they self-monitored at particular times, 
with the same participant often having different imme-
diate motives on different occasions.
For all but one participant, SMBG was carried out 
routinely, forming part of everyday practice, for at least 
some of the time.
I take it [blood glucose reading] as soon as I get up in the 
morning before I do anything. (Angus)
copyright.
 o
n
 20 Septem
ber 2018 by guest. Protected by
http://drc.bmj.com/
BM
J O
pen Diab Res Care: first published as 10.1136/bmjdrc-2018-000538 on 19 September 2018. Downloaded from 
3BMJ Open Diab Res Care 2018;6:e000538. doi:10.1136/bmjdrc-2018-000538
Table 1 Characteristics of the 10 cases
Case: 
participant 
pseudonym
Age
(years)
Diabetes 
mellitus 
type
Diabetes 
mellitus 
duration 
(years) Occupation Living situation
Support 
person
Healthcare 
professional 
pseudonym Diary
Michelle <20 1 5–10 Student Alone Mother –
Maureen 45–50 1 >20 Housewife With spouse/
children
Spouse Dr Hay
Angus 70–75 1 15–20 Retired professional With spouse Spouse – √
Tam 65–70 2 5–10 Unemployed 
pensioner
With partner Partner – √
Brian 65–70 1 >20 Retired non-
professional
Alone Partner Podiatrist 
Colin
√
Pauline 55–60 1 <5 Healthcare 
professional
Alone – Dr Whitby √
Alison 45–50 1 >20 Healthcare 
professional
With spouse Friend Dietitian Sally √
Bill 70–75 2 >20 Retired non-
professional
With partner Partner –
Peter 60–65 2 15–20 Retired professional Alone – –
Charles 60–65 2 5–10 Retired professional Alone – – √
Psychosocial Research
Routine testing generally involved testing at certain 
points in the day and/or at mealtimes, usually at home. 
Interestingly, the only participant who did not routinely 
monitor considered HbA1c to be the more important 
marker of glycemic control.
I mean the key measure is always HbA1c, that’s the target, 
I’ve always been encouraged to consider it the target 
variable. (Charles)
The routine nature of testing was noted to be ingrained 
and built on past experiences, with the impression that 
some participants would not consider changing practices 
they had undertaken for many years.
Aye this guy’s an old hand you see, he’s been type 1 for 
45 years and he’s fairly set in his ways. (Podiatrist Colin)
The entire range of responses was observed for routine 
SMBG, from no action to higher level analytical responses 
(table 2).
For many participants, there was a notable change in 
behavior around SMBG and associated self-management 
prior to, or following, a diabetes review or clinic appoint-
ment. These changes included initiation of testing after 
a period of non-testing, an increase in testing frequency, 
or payment of more attention to testing, evidenced 
through documenting results and subsequent responses. 
In general, the responses were either lacking, or reactive 
and short term. Michelle stated explicitly that this was an 
important motive for testing:
Yes, yes … (giggle) … Yeah so maybe in the week running 
up to an appointment, I probably do more testing than 
I should be because I’m trying to almost work harder to 
have these where they should be so they are not seeing 
results way down at the bottom or way up at the top, so, 
I just pray they don’t go too far enough back to see the 
other ones … (giggle) … (Michelle)
Indeed, all four HCPs were aware that SMBG behav-
iors could sometimes be directly linked to clinic visits and 
perhaps a desire by people to show that they were ‘good 
patients’.
Maybe the two weeks prior to their visit to the clinic may 
be different to normality … well, yes … so in the patient’s 
view, they will be ‘behaving themselves’, … but I think 
sometimes the patient will behave differently if they know 
that an appointment is imminent and they are starting 
to check where they wouldn’t have checked particularly 
before. (Podiatrist Colin)
Some participants tested when they thought that their 
result would be at the required level: “almost when it’s, 
it’s fine” (as a mother of a young person with diabetes 
commented in pilot data). There would be no action in 
response. A fear of seeing high blood sugar results, and 
also not wanting or having the time to act on these, was 
an important factor in this, as one HCP explained; people 
may well avoid testing when they suspect that results will 
be outwith the desired range.
There are other patients who will avoid monitoring at 
times when they know that it’s going to be an abnormal 
result, because they don’t want to deal with it. (Dr Whitby)
Given the difficulties people have regarding the juggling 
of work and family commitments, being prepared for 
“abnormal” results and allowing time to respond to them 
influenced testing and timing of the test.
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Table 2 Summary of actions/responses to self-monitoring 
of blood glucose (SMBG) reported to have been carried out 
for each immediate motive for monitoring
Immediate motive
Actions/responses 
reported
Routine Full range of actions/
responses
Prior to, or following, a 
diabetes review or clinic 
appointment
No action, reactive actions, 
short-term actions
Know result will be at good/
stable level
No action
To facilitate everyday lifestyle 
activities
Short-term actions, longer 
term actions
In response to physical 
symptoms
Full range of actions/
responses
Higher level analytical 
motives
Higher level analytical 
responses
Key to actions/responses:
No action: result might be documented but no further action 
taken.
Reactive actions: immediate action taken involving little thought, 
usually glucose/carbohydrate intake or the administration of 
insulin.
Short-term actions: some thought given to SMBG result and the 
required response; for example, carbohydrate intake or insulin 
taken with consideration of future energy expenditure.
Long-term actions: consideration of the type and level of action 
taken, rechecking the effect of actions, and consideration of future 
carbohydrate intake and energy expenditure over the rest of the 
day and possibly into the next.
Higher level analytical responses: movement beyond long-term 
thinking to questioning why blood glucose levels move to the 
levels they do, looking at results together in the context of life and 
lifestyle, and analyzing this over several days.
Psychosocial Research
It gives you an answer maybe that you don’t want, because 
actually you don’t want to know that you’re less than 5, 
when you know you’ve got to pick your child up from 
gymnastics in 10 min, because you can’t, you’ve got to do 
something about your diabetes first (laugh). (Dietitian 
Sally)
A fourth important immediate motive for SMBG was to 
facilitate everyday lifestyle activities, specifically to enable 
driving (underpinned by legislative requirements) or 
to allow participants leeway to consume the food and 
drink (including alcohol) that they wished (which might 
involve accepting blood glucose levels at higher than 
recommended limits). Associated responses could be 
short or longer term. Driving was specifically mentioned 
by seven of the ten participants with diabetes, and HCPs 
also recognized that driving was a strong motive.
Just because it’s so much easier to control your life … I 
have to do it before eating and before driving, so it has 
to be over 5 to drive, and because I do drive quite a lot 
obviously for work, I’m taking mine a bit more than the 
average person is. (Pauline)
Tam, Brian, Pauline and Michelle all referred to SMBG 
as affording them the confidence to consume food and 
drink that are not part of recommended diabetes dietary 
plans, and Charles explicitly gave as a reason for testing: 
“if I fancy a dessert or something.”
All participants referred to testing in response to phys-
ical symptoms, mostly those associated with low blood 
glucose. These symptoms were reported to be more 
noticeable and unpleasant than those of high blood 
glucose. The entire range of responses was observed in 
relation to this immediate motive.
Eh … no so much when you go high like, it’s more when 
you are going doon to 2 or 3, you can actually feel it … 
within yourself … I’ve never had anything when it goes 
high, I’ve never felt oot of sync or that when it’s high … 
but in the mornings when it’s low … you can feel it, but 
as I’ve said, it’s gone up to 30, I don’t feel any different. 
(Tam)
Finally, higher level analytical motives, such as the 
desire to control blood glucose levels over a longer 
period and even to reduce risks associated with poor 
diabetes control, were evident for a minority of partic-
ipants. These motives initiated responses whereby the 
individual engaged in problem-solving, forward or 
longer term planning and analytical thinking, and were 
observed to differing levels by Alison, Maureen and Bill. 
They followed up on actions, whereby they would test 
again following an action taken in order to check its 
effect on blood glucose levels.
Already I’m thinking, well if it says, whatever the result is, 
well I’m having that for tea, so therefore what’ll mean, em 
or I’ll go and do, I’m going away out and/or exercising, 
so if it’s that, then I’m eating that and I need to cut back 
on the insulin because of that later. (Alison)
The immediate motives for testing are listed in table 2. 
There were also different actions/responses made to 
testing. These were categorized as no action, reactive 
action, short-term action, longer term action, and higher 
level analytical responses. They are defined in table 2, 
and the different actions/responses reported by partic-
ipants are listed for each motive.
On further analysis, it became clear that there were 
several prominent beliefs and attitudes surrounding 
diabetes that were held to varying degrees by different 
participants with diabetes. These appeared to underpin 
the immediate motives for SMBG and subsequent 
responses. Figure 1 shows how these concepts fit into 
the theoretical model. The underlying attitudes held 
by people with diabetes toward SMBG are part of their 
‘internal structures’, that is, what they know and their 
general and specific understandings, which influence the 
‘actions’ that they take. The actions can be viewed as both 
the SMBG process itself and the responses to the test 
result. The immediate motive for SMBG can be viewed as 
another mediating layer.
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Figure 1 How concepts fit into the theoretical model. HCP, healthcare professional.
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level of engagement
A very important underlying attitude was level of engage-
ment with diabetes. At one end of the spectrum, one 
participant (Tam) was sometimes so disengaged with his 
diabetes on a day-to-day basis that he often ate what he 
liked and could forget to inject insulin.
… but there is … you do forget sometimes … I even 
forget sometimes to inject myself. (Tam)
The most common and sometimes the only observed 
immediate motive for disengaged participants was 
routine SMBG that involved little thought. In contrast, 
another participant (Alison) was fully engaged with her 
diabetes and referred to it as “part of me.” She was one of 
the few participants who exhibited higher level motives 
for SMBG.
Responsibility
The extent to which the participant felt it was their 
responsibility to manage their diabetes was linked to 
level of engagement. Alison explicitly stated that she felt 
responsible, as did Brian, while Bill spoke about a lack of 
responsibility in others. By definition, those who tested 
to facilitate their lifestyle were showing some degree of 
responsibility (although this could be relatively short 
term), while participants with higher level motives exhib-
ited high levels of responsibility.
It’s my body, right, with eh, the tools and the information 
that I’ve got already, then it’s up to me to manage my 
body and that’s what I’m trying to do. (Brian)
Ignoring it, it’s stupid, I know folk that do that. (Bill)
diabetes education
Engagement and responsibility were facilitated by 
diabetes education, but it was evident that there were 
different levels of desire, need and access to education, 
or indeed to understand diabetes.
There’s good quality education out there, some want it, 
some don’t and as I say some don’t have access to the 
things they want. (Dietitian Sally)
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Level of diabetes education was associated with the 
immediate motive for testing. A certain level of educa-
tion is necessary for longer term planning and thus 
‘higher-level motives’, while routine SMBG was observed 
particularly among those whose knowledge was limited 
or more outdated, not necessarily through any fault of 
their own. This was recognized by HCPs.
Patients with longstanding diabetes were educated at 
a time when insulin dose adjustment wasn’t something 
we recommended and we tended to dictate what the 
solutions were rather than encouraging patients to self-
manage which is what we do now. (Dr Whitby’s comments 
on diary extracts)
desire for control
The desire for control was an underlying theme: the 
desire of participants to control diabetes, rather than be 
controlled by it, and to manage or to reclaim their lives, 
that is, have a good quality of life and not let diabetes 
take over. For example, Pauline felt she was able to and 
wanted to manage her life without “dwelling” on diabetes. 
There was a real focus on how SMBG worked to allow her 
to manage her life as she would without diabetes, rather 
than as a tool to manage diabetes effectively.
… but it’s great just getting on with life (laugh) and not 
worrying about it too much …. I don’t dwell on it, I just 
get on with it. (Pauline)
Maureen, on the other hand, recognized that when she 
lost control, it affected her confidence and self-efficacy. 
She elaborated: “the last year, I’ve been having lots of problems 
due to my diabetes, so I don’t feel as confident as I did before.”
Facilitating everyday activities through SMBG was one 
way in which participants could manage their own lives, 
as Pauline explained: “It’s so much easier to control your life, 
because you have the choice … your life’s not different, well you 
know what I mean.”
However, this study also revealed that people with 
diabetes acknowledge behaviors and subsequent read-
ings that would not be advocated by HCPs, and that 
this can be driven by a desire for ‘normality’, making 
informed decisions to do something enjoyable in the 
knowledge that this might not necessarily lead to optimal 
self-management. At least three participants referred to 
experiencing high blood glucose levels as a result of their 
chosen behaviors. Brian’s diary provides a somewhat 
humorous illustration of this tendency.
Day 2: Before evening meal=14.2 … this is ok after 2 pints 
of beer, most enjoyable. Day 3: Before evening meal=16.4 
… that’s ok after 4 pints of beer, well it is Saturday … I can 
live with it … let’s see what happens tomorrow. (Brian’s 
diary extract)
Brian explained, “I’m not saying I’m managing it perfectly, 
but I’m managing it to my satisfaction … and I’m happy with 
that … if you can understand that.”
It is important that HCPs are aware of the trade-offs 
that people with diabetes feel they need to make, as 
podiatrist Colin explains about Tam, and Dr Whitby indi-
cates in her comments on Brian’s diary extract:
He quite simply doesn’t want to change, he’s happy with 
the way his diabetes is controlled, eh, he’s happy with 
the way he can function … it’s his habit to socialize with 
his friends at the pub between 4 and 6pm (laugh), he 
doesn’t want anything to distract from his quality of life. 
(Podiatrist Colin)
He sees his actions as common sense actions again a 
feature of long-standing diabetes, many habits and beliefs 
are ingrained … if he cannot continue with his ritual of a 
couple of pints, he will lose control. (Dr Whitby)
Resistance
Some participants with diabetes resisted ‘interference’ in 
their diabetes, which seemed to be linked to their efforts 
to retain control over their lives and their condition. 
Resistance was played out in several ways: resistance to 
HCPs and their advice, resistance to support persons, or 
resistance to the condition itself.
Brian provided an example of someone who resisted 
hospital-based control in an effort to reclaim ‘normality’:
I suppose that’s my little bit of rebellion; like wanting to 
be normal (laugh) … and there’s nothing they [hospital 
clinic doctors] can do about it (laugh). (Brian)
On the other hand support people explained their 
early experiences with providing support to their chil-
dren, which could initiate angry outbursts or resentment.
I had to get a grip and kind of step back because you 
know I think she got so fed up with me continually asking 
her if she’s taken her Lantus [long acting insulin] or 
done this or done that, you know (pilot data) the more I 
ask the more she gets angry. (Michelle’s mother)
Resistance was also observed toward the condition 
itself, partly from a wish not to be identified by it, as 
exemplified by Tam.
I mean, I know couple of people that are diabetic and I 
dinnae go and talk aboot it with them, you know it’s not 
really eh, I don’t think it would benefit me. (Tam)
Similarly, Michelle’s mother believed that Michelle 
does not engage with her diabetes “because of this whole 
thing of not wanting to identify with her diabetes … or … you 
know.”
Resistance and denial were associated with routine 
testing without acting on the blood glucose results, and 
also testing before a clinic appointment or when the 
participant knew the result would be good.
Relationship with the health service and HCPs
The hierarchical or paternalistic model of care was 
perceived by some participants to be the dominant one, 
along with a desire to be regarded as ‘compliant’, doing 
what they were told to do and gaining approval from 
HCPs (whether or not they were actually compliant in 
practice). This attitude was particularly evident with Tam:
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Cause they were’na happy with me when I was in the last 
time … eh they were’na happy with me then. (Tam)
Michelle’s non-collaborative relationship with HCPs, 
described by her mother, was related to her impression 
of SMBG as a “test” where she was being assessed or felt 
she was being judged. This is apparent from some of the 
terminology that she used (eg, “scores”).
She goes in she gets out again as quickly as she can … 
it’s not a collaborative experience, it’s not a supportive 
experience. (Michelle’s mother)
You had to write down all your scores and they went 
round the room, which was ‘ah no!’… (Michelle)
The main immediate motives for SMBG for such partic-
ipants were when a clinic appointment was coming up or 
when they knew the result would be good. In contrast, 
other participants reported an effective and collabo-
rative relationship with their HCPs (and thus a more 
concordant model of care). These were the participants 
who were more likely to report higher level motives for 
testing.
… they will say … you are doing really well, you are doing 
what you can do with the tools you have. (Alison)
Fear of hypoglycemia
Fear of hypoglycemia was dominant among participants 
with diabetes and was the main driver for testing in 
response to physical symptoms.
It scares the shit out of me … I don’t want to have another 
hypo, right, I don’t want to! (Brian)
This fear was recognized by Dr Whitby who explained 
it thus:
People have a fear of hypos because of the neurological 
symptoms, risk of unconsciousness and the need for third 
party help if it’s severe … I think it is easier to ignore 
something that doesn’t have an immediate adverse 
outcome like a hypo. (Dr Whitby)
In general, participants were much less concerned or 
cognizant of symptoms relating to high blood glucose 
levels, with Tam, for example, “more frightened about it 
going doon … than going high.”
Prevention of long-term complications
That SMBG was carried out in order to achieve good 
diabetic control for the prevention of long-term compli-
cations was explicitly articulated, to a varying extent, by 
only three participants with diabetes. This recognition 
was required for them to exhibit higher level motives for 
testing. There was a clear awareness among them of goals 
or targets in relation to SMBG, in contrast to viewing 
goals as a notion referred to during consultation with 
HCPs but not something that is achievable in reality.
dIsCussIOn
This study indicates that SMBG is not a stand-alone process 
but takes place within a complex set of external and internal 
structures. It has been argued that failure to find evidence 
for an association between SMBG and improved glycemic 
control relates to factors such as lack of understanding of 
what the measurements mean, how they should be used, 
and how individuals might make changes to insulin dose 
and other practices.10 However, we have shown that it seems 
to be relatively uncommon for people to test with a view to 
improving long-term glycemic control. In fact, many have 
other motives for testing: as a matter of routine, to facili-
tate everyday activities, to demonstrate adherence, and to 
impress HCPs (and themselves) when results are ‘good’. 
These motives seem to be related to underlying attitudes 
(internal structures) surrounding diabetes itself.
Several qualitative studies have identified other 
constructs that have implications for diabetes self-care in 
general.11 These include level of engagement, resistance 
to a diabetic identity, different degrees of personal respon-
sibility and the challenges of trying to retain a ‘normal’ 
life. We have shown that they also affect whether and how 
SMBG is carried out. Self-management practices may also 
change and develop over time.11 There have been calls 
for educational interventions to improve knowledge and 
understanding surrounding SMBG in terms of how to 
carry out SMBG operationally. There have also been calls 
for educational interventions relating to interpretation 
of results.12 Others have recognized the importance of 
addressing motivation and behavior change.13 However, 
we have shown that the barriers to effective SMBG may be 
much more fundamental than this. The diabetes-related 
attitudes and beliefs that individuals hold (internal struc-
tures) have direct implications for SMBG practices and 
associated responses.
The nature of the relationship between the individual 
and the health service is also of paramount importance. 
This is recognized by Diabetes UK, who stress that HCPs 
should work in partnership with people with diabetes 
on a patient-by-patient basis to decide jointly on testing 
frequency.14 However, very few patient participants in our 
study appeared to work collaboratively with their HCPs. 
This lack of collaboration in diabetes care has been high-
lighted elsewhere, with doctor-centered consultation styles 
driving the ‘compliance’ model of communication rather 
than the ‘concordant’ approach that is assumed to be the 
norm.15 While it has been argued that diminishing trust 
in healthcare by the public also poses challenges to the 
concordant (or collaborative) model,16 a lack of trust did 
not appear to be at the root of less than optimal SMBG 
practices and behaviors among our patient participants, 
but rather there was a disconnect between the ideal medical 
model of diabetes care and what mattered to them, with 
some of them willing to compromise optimum diabetes 
care and future health in order to lead the lifestyle that was 
important to them.
This study has thus shown that there needs to be a move 
away from a prescriptive approach to SMBG where ‘one 
size fits all’, and an attempt to understand individuals in 
the context of their own lives, the internal beliefs that 
they hold and the external structures surrounding them. 
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By using structuration theory to inform the design and 
analysis, we have highlighted the importance of internal 
structures in the SMBG process (people’s experiences, 
backgrounds, viewpoints, skills and knowledge). These are 
represented in underlying attitudes toward diabetes. They 
are also influenced by the external social, economic and 
material environment. For example, while provision of 
diabetes education and relationship with HCPs are a direct 
product of the external environment, other attitudes and 
motives (eg, desire to have a certain lifestyle or to drive) are 
influenced by social and material circumstances.
Important strengths of this study include the recruit-
ment of a diverse set of cases, with detailed information 
collected for each one from several sources. There were six 
patient participants with type 1 diabetes and six with type 
1 diabetes, including some recently diagnosed and some 
with diabetes for over 20 years. There was also a wide age 
range (although we were unable to recruit any patient 
participant in the age group 20–45 years old). However, 
although the sample size was ample for a case study, the 
study was undertaken in a single Scottish Health Board. It 
was not possible to obtain a full set of data for all ten cases 
(two participants were unable to identify a support person 
and not all completed diaries) and no HCPs were recruited 
from general practice. While we ensured that a selection of 
transcripts were coded independently by all three authors 
and the framework was developed through discussion 
between them to allow for varied and richer interpreta-
tions of the data, it is still possible that this study was influ-
enced by individual researchers’ backgrounds and beliefs. 
Nevertheless, this study has highlighted the importance 
of taking into account the real-world context for individ-
uals when they practice SMBG and self-management, if we 
wish to understand and support effective self-management 
behavior. This may involve HCPs taking a more collabo-
rative and realistic approach, involving shared decisions 
about self-management, and the setting of achievable goals 
that are mindful of patients’ wants and needs in the context 
of their everyday lives.
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